Please login to the form below

Not currently logged in
Email:
Password:

Catena

This page shows the latest Catena news and features for those working in and with pharma, biotech and healthcare.

BioMarin files muscular dystrophy drug in EU

BioMarin files muscular dystrophy drug in EU

Other companies bringing DMD therapies through the pipeline include Santhera, whose Raxone/Catena (idebenone) candidate has completed phase III testing.

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...

Infographics